The Energy Code

What if osteoarthritis isn’t primarily a “wear and tear” problem, but a mitochondrial problem inside living joint tissue? In this episode, Dr. Mike Belkowski connects five distinct (but converging) strategies through one lens: joint degeneration as an energy + redox + immune-metabolic disorder. You’ll hear how oxidative stress can act like an upstream “wiring harness” for inflammation, why intra-a...

This Deep Dive introduces resveratrone, a newly described compound created via photoconversion of resveratrol. The paper’s core argument is that resveratrone is structurally distinct enough to behave like a different molecule — and in a suite of skin-relevant assays (antioxidant capacity, melanin/tyrosinase biology, fibroblast activity, collagen synthesis, and acne-associated antimicrobial effects...

This Deep Dive breaks photoaging out of the “cosmetic” category and reframes it as a systems-level loss of cellular resilience driven by ultraviolet exposure and mitochondrial stress. UVA and UVB create different injury patterns — UVB skewing toward more direct DNA damage in the epidermis, UVA driving deeper dermal oxidative stress that impacts fibroblasts and collagen architecture. The paper’s ce...

This Deep Dive reframes age-related macular degeneration (AMD) as more than “aging eyes” or vascular/inflammatory drift. The core argument: AMD may be a mitochondrial quality-control disease, especially in the retinal pigment epithelium (RPE), which is the high-demand support layer that keeps photoreceptors alive. As mitochondrial dynamics break down (excess fission, reduced fusion, reduced biogen...

Oral infections aren’t “just a mouth problem” — they’re biofilm problems, delivery problems, and resistance problems. This Deep Dive breaks down a review on photosensitized methylene blue nanoparticles as a next-generation approach for controlling oral pathogens. Instead of relying on free methylene blue (which can disperse fast, stain, and fall short in biofilms), the paper explores methylcellulo...

Most people think circadian rhythm is just “sleep timing.” This Deep Dive flips that model on its head using a plant biology review with a human-relevant message: energy is not just about fuel — energy is about timing. The circadian clock doesn’t simply respond to sunlight; it’s shaped from the inside by metabolic cues from chloroplasts and mitochondria — sugars, redox state, ROS, organic acids, a...

Hashimoto’s thyroiditis is usually treated like a numbers problem: TSH normalizes, levothyroxine is “working,” end of story. But many patients live in a different reality: persistent fatigue, poor sleep, brain fog, low mood, pain, and a feeling of being drained even when labs look fine. In this Deep Dive, Dr. Mike breaks down a study that tested photobiomodulation (PBM) applied over the thyroid re...

Most weight-loss advice stops at “calories in vs. calories out.” In this episode, Dr. Mike goes deeper: what happens to your body’s energy machinery during weight loss and why maintenance can be harder than the initial drop. Using four papers (two skeletal muscle mitochondrial studies, one PBM body-contouring study, and one chlorin e6 photodynamic obesity study in mice), you’ll learn how weight lo...

Transcranial photobiomodulation (tPBM) is everywhere in performance culture —shine near-infrared light on the prefrontal cortex and supposedly you get better oxygenation, lower perceived effort, delayed central fatigue, and improved endurance. This Deep Dive episode breaks down a clean, double-blind crossover study in trained cyclists who rode their own bikes through a standardized constant-load e...

Can photobiomodulation (red + near-infrared light) meaningfully improve glycemic control in people with type 2 diabetes? In this Deep Dive, Dr. Mike Belkowski breaks down a 2026 systematic review of randomized clinical trials that tested PBM for diabetes outcomes like fasting glucose, post-prandial glucose, and HbA1c. The evidence base is small — only 4 RCTs met strict inclusion criteria (control/...

Most conversations about Alzheimer’s and mitochondria stay in broad strokes. This Deep Dive episode doesn’t. Dr. Mike Belkowski breaks down a study that examined postmortem human brain tissue to answer a precise question: do mitochondrial electron transport chain proteins shift in Alzheimer’s the same way they shift in normal aging — or is Alzheimer’s a different mitochondrial pattern entirely? Us...

Mitophagy is the body’s targeted mitochondrial cleanup system; not general autophagy, but the precise identification and removal of damaged mitochondria so cells can recycle parts and rebuild stronger. In this Deep Dive, Dr. Mike Belkowski breaks down a newly published review, “Mitophagy in the Pathogenesis and Management of Disease,” and explains why mitophagy is more than housekeeping — it’s a s...

Reactive oxygen species (ROS) sit at the center of modern cancer biology and the conversation around them is often wildly oversimplified. In this Deep Dive, Dr. Mike Belkowski explains why ROS are not “bad molecules,” but cellular signaling messengers that can be hijacked by tumors. The core framework is the one you need to remember: ROS has a dual role in cancer —moderate ROS can support tumor gr...

Red and near-infrared light (photobiomodulation) is hitting a legitimacy inflection point; not because it “does everything,” but because the science has matured enough to demand standards. In this Deep Dive, Dr. Mike Belkowski breaks down why mainstream outlets like Nature are taking red light seriously now, what that signals about the lifecycle of a real therapy (research → niche clinics → overhy...

This episode builds a real framework for chronic pain by connecting two worlds that rarely get stitched together: (1) a mechanistic review arguing that mitochondrial dysfunction drives pain chronification, and (2) a systematic review of randomized clinical trials on photobiomodulation (PBM) — red/near-infrared light therapy — for chronic pain. Dr. Mike Belkowski explains why chronic pain is a bioe...

Pancreatic cancer is aggressive, often detected late, and notoriously resistant to standard chemotherapy. In this Deep Dive, Dr. Mike Belkowski breaks down a major frontier in oncology research: targeted mitochondrial therapy. You’ll learn why mitochondria sit at the center of tumor survival (energy production, redox control, metabolic flexibility, calcium signaling, and, most importantly, apoptos...

Most people think of asthma as tight airways and allergies. This Deep Dive reframes it as something deeper: inflammation + oxidative stress + mitochondrial bioenergetics. Using a revised research manuscript on an ovalbumin-induced allergic asthma mouse model, we walk through how methylene blue (MB) impacted the biology; not “curing asthma,” but attenuating airway inflammation and oxidative stress...

Aging isn’t just time, it’s immune balance drifting out of control, and one of the most consistent signatures is inflammaging: chronic, low-grade inflammation that never fully resolves. This Deep Dive breaks down a mechanistic paper proposing that urolithin A (UA), a gut-derived metabolite linked to mitochondrial quality control, may protect the aging liver by stabilizing a key anti-inflammatory r...

Blue light has real antimicrobial potential in the mouth, especially against black-pigmented periodontal bacteria. But most people skip the more important question: what does blue (and violet) light do to your own gum tissue? This Deep Dive breaks down a study testing primary human gingival keratinocytes (barrier cells) and gingival fibroblasts (repair/remodeling cells) under 457nm blue vs 418nm v...

Neurodevelopmental disorders like autism spectrum disorder, ADHD, and Rett syndrome are complex and highly individualized. With that being said, a 2026 review highlights a recurring biological theme across many cases: mitochondrial dysfunction as a systems-level vulnerability. This Deep Dive focuses on mitochondrial dynamics: how mitochondria split (fission), merge (fusion), move to synapses (tran...

Mood isn’t just neurotransmitters—it’s stability. In this deep dive, Dr. Mike Belkowski connects circadian rhythm, mitochondrial function, and mood regulation through a simple idea: your brain’s energy system runs on a daily schedule. Mitochondrial output, redox tone, calcium buffering, and mitochondrial cleanup all oscillate across the day—and when modern life disrupts that rhythm (late nights, i...

In this week’s solo episode of The Energy Code, Dr. Mike Belkowski explores a major evolution in mitochondrial support: the transition from pharmacologic intervention to biological nourishment. Dr. Mike introduces BioBlue Aqua, a formula that replaces synthetic methylene blue with organic, high-purity blue spirulina to align with the body's natural evolutionary architecture. Dr. Mike unpacks the f...

This Deep Dive isn’t about testing red light therapy in a lab, it’s about testing the information environment. A 2025 study analyzed how at-home red light therapy devices are promoted on Instagram and TikTok, and whether social media claims match what dermatology evidence can actually support. Using fresh accounts to reduce algorithm bias, researchers reviewed 132 posts with a combined potential r...

What if the real upgrade in regenerative aesthetics isn’t a new injectable, it’s preconditioning the injectable? This Deep Dive breaks down a hypothesis-generating review proposing “mitochondria-targeted biophysical priming”: applying controlled physical energy (red/NIR light, ultrasound, mechanical cues) to autologous biologics inside a closed sterile system before injection. The idea is simple b...

Transcranial photobiomodulation (tPBM) is blowing up in performance culture, but what does the evidence actually say? In this Deep Dive, Dr. Mike Belkowski breaks down a narrative review (7 studies total: 5 human, 2 animal) examining tPBM in sports medicine for performance enhancement and injury prevention. You’ll learn the proposed mechanisms (mitochondrial respiration via cytochrome c oxidase, n...